Skip to main content

Find Clinical Trials

Home
Conditions
Type 2 Diabetes Mellitus

Clinical trial condition

Type 2 Diabetes Mellitus

Explore clinical trials studying Type 2 Diabetes Mellitus. Study availability and eligibility vary by location and protocol.

1,509 public trials 41 recruiting studies

Refine in advanced search Browse all conditions

Type 2 Diabetes Mellitus trial results

Completed

Safety, Tolerability and Pharmacodynamics of CYT013-IL1bQb in Patients With Type 2 Diabetes

NCT00924105

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Cytos Investigator sites Hamburg, Germany

Cytos Investigator sites Basel, Switzerland

Cytos Investigator sites Zurich, Switzerland

View Trial Details

Completed

Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in Japan

NCT01263496

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan

NCT01263509

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan

NCT01318122

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan

NCT01263483

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety of Alogliptin Used Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan

NCT01318070

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan

NCT01318083

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Safety, Tolerability and Activity Study of Multiple Doses of ISIS-SGLT2Rx in Healthy Volunteers

NCT00836225

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Center for Human Drug Research Leiden, Netherlands

View Trial Details

Completed

Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in Japan

NCT01318109

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Pharmacodynamic Effects of Single-Dose Co-Administration of LX4211 With Januvia® in Type 2 Diabetics

NCT01441232

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Lexicon Investigational Site San Antonio, Texas, United States

View Trial Details